BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 36763035)

  • 1. Potential Antihuman Epidermal Growth Factor Receptor 2 Target Therapy Beneficiaries: The Role of MRI-Based Radiomics in Distinguishing Human Epidermal Growth Factor Receptor 2-Low Status of Breast Cancer.
    Bian X; Du S; Yue Z; Gao S; Zhao R; Huang G; Guo L; Peng C; Zhang L
    J Magn Reson Imaging; 2023 Nov; 58(5):1603-1614. PubMed ID: 36763035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric MR Imaging Radiomics Signatures for Assessing the Recurrence Risk of ER+/HER2- Breast Cancer Quantified With 21-Gene Recurrence Score.
    Chen Y; Tang W; Liu W; Li R; Wang Q; Shen X; Gong J; Gu Y; Peng W
    J Magn Reson Imaging; 2023 Aug; 58(2):444-453. PubMed ID: 36440706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination between HER2-overexpressing, -low-expressing, and -zero-expressing statuses in breast cancer using multiparametric MRI-based radiomics.
    Zheng S; Yang Z; Du G; Zhang Y; Jiang C; Xu T; Li B; Wang D; Qiu Y; Lin D; Zhang X; Shen J
    Eur Radiol; 2024 Feb; ():. PubMed ID: 38363315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra- and Peritumoral Based Radiomics for Assessment of Lymphovascular Invasion in Invasive Breast Cancer.
    Jiang W; Meng R; Cheng Y; Wang H; Han T; Qu N; Yu T; Hou Y; Xu S
    J Magn Reson Imaging; 2024 Feb; 59(2):613-625. PubMed ID: 37199241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of MRI Radiomics Models to Differentiate HER2-Zero, -Low, and -Positive Breast Cancer.
    Peng Y; Zhang X; Qiu Y; Li B; Yang Z; Huang J; Lin J; Zheng C; Hu L; Shen J
    AJR Am J Roentgenol; 2024 Apr; 222(4):e2330603. PubMed ID: 38265001
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers.
    Ramtohul T; Djerroudi L; Lissavalid E; Nhy C; Redon L; Ikni L; Djelouah M; Journo G; Menet E; Cabel L; Malhaire C; Tardivon A
    Radiology; 2023 Aug; 308(2):e222646. PubMed ID: 37526540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral and Peritumoral Analysis of Mammography, Tomosynthesis, and Multiparametric MRI for Predicting Ki-67 Level in Breast Cancer: a Radiomics-Based Study.
    Jiang T; Song J; Wang X; Niu S; Zhao N; Dong Y; Wang X; Luo Y; Jiang X
    Mol Imaging Biol; 2022 Aug; 24(4):550-559. PubMed ID: 34904187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
    Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K
    Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Radiomics to Differentiate Brain Metastases From Lung Cancer Versus Breast Cancer, Including Predicting Epidermal Growth Factor Receptor and human Epidermal Growth Factor Receptor 2 Status.
    Shi J; Chen H; Wang X; Cao R; Chen Y; Cheng Y; Pang Z; Huang C
    J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):924-933. PubMed ID: 37948368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative MRI-Based Radiomics of Brain Metastasis to Assess T790M Resistance Mutation After EGFR-TKI Treatment in NSCLC.
    Fan Y; He L; Yang H; Wang Y; Su J; Hou S; Luo Y; Jiang X
    J Magn Reson Imaging; 2023 Jun; 57(6):1778-1787. PubMed ID: 36165534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics Signatures Based on Multiparametric MRI for the Preoperative Prediction of the HER2 Status of Patients with Breast Cancer.
    Zhou J; Tan H; Li W; Liu Z; Wu Y; Bai Y; Fu F; Jia X; Feng A; Liu H; Wang M
    Acad Radiol; 2021 Oct; 28(10):1352-1360. PubMed ID: 32709582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric MRI-based radiomics nomogram for predicting the hormone receptor status of HER2-positive breast cancer.
    Sang L; Liu Z; Huang C; Xu J; Wang H
    Clin Radiol; 2024 Jan; 79(1):60-66. PubMed ID: 37838543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Assessment of MRI-Invisible Early-Stage Endometrial Cancer With MRI-Based Radiomics Analysis.
    Jiang X; Song J; Zhang A; Cheng W; Duan S; Liu X; Chen T
    J Magn Reson Imaging; 2023 Jul; 58(1):247-255. PubMed ID: 36259352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of Radiomics-Based Feature Analysis on Multiparametric Magnetic Resonance Images for Noninvasive Meningioma Grading.
    Laukamp KR; Shakirin G; Baeßler B; Thiele F; Zopfs D; Große Hokamp N; Timmer M; Kabbasch C; Perkuhn M; Borggrefe J
    World Neurosurg; 2019 Dec; 132():e366-e390. PubMed ID: 31476455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
    Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
    J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elaboration of Multiparametric MRI-Based Radiomics Signature for the Preoperative Quantitative Identification of the Histological Grade in Patients With Non-Small-Cell Lung Cancer.
    Tang X; Bai G; Wang H; Guo F; Yin H
    J Magn Reson Imaging; 2022 Aug; 56(2):579-589. PubMed ID: 35040525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
    Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
    J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast Cancer.
    Braman N; Prasanna P; Whitney J; Singh S; Beig N; Etesami M; Bates DDB; Gallagher K; Bloch BN; Vulchi M; Turk P; Bera K; Abraham J; Sikov WM; Somlo G; Harris LN; Gilmore H; Plecha D; Varadan V; Madabhushi A
    JAMA Netw Open; 2019 Apr; 2(4):e192561. PubMed ID: 31002322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive ductal breast cancer: preoperative predict Ki-67 index based on radiomics of ADC maps.
    Zhang Y; Zhu Y; Zhang K; Liu Y; Cui J; Tao J; Wang Y; Wang S
    Radiol Med; 2020 Feb; 125(2):109-116. PubMed ID: 31696388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric MRI-Based Radiomics Nomogram for Predicting Lymph Node Metastasis in Early-Stage Cervical Cancer.
    Xiao M; Ma F; Li Y; Li Y; Li M; Zhang G; Qiang J
    J Magn Reson Imaging; 2020 Sep; 52(3):885-896. PubMed ID: 32096586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.